Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011, Article ID 121258, 5 pages
http://dx.doi.org/10.1155/2011/121258
Case Report

X-Linked Lymphoproliferative Syndrome and Common Variable Immunodeficiency May Not Be Differentiated by SH2D1A and XIAP/BIRC4 Genes Sequence Analysis

Department of Pediatric Immunology, Ege University Medical School, 35100 Izmir, Turkey

Received 29 September 2010; Revised 3 January 2011; Accepted 19 February 2011

Academic Editor: Robert A. Eisenberg

Copyright © 2011 Nesrin Gulez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Rigaud, M. C. Fondaneche, N. Lambert et al., “XIAP deficiency in humans causes an X-linked lymhoroliferative syndrome,” Nature, vol. 444, no. 7115, pp. 110–114, 2006. View at Google Scholar
  2. N. Nagy, K. Mattsson, A. Maeda, A. Liu, L. Székely, and E. Klein, “The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells,” Immunology Letters, vol. 82, no. 1-2, pp. 141–147, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Brandau, V. Schuster, M. Weiss et al., “Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP),” Human Molecular Genetics, vol. 8, no. 13, pp. 2407–2413, 1999. View at Google Scholar · View at Scopus
  4. S. Latour, “Natural killer T cells and X-linked lymphoproliferative syndrome,” Current Opinion in Allergy and Clinical Immunology, vol. 7, no. 6, pp. 510–514, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Rigaud and S. Latour, “An X-linked lymphoproliferative syndrome (XLP) caused by mutations in the inhibitor-of-apoptosis gene XIAP,” Medecine/Sciences, vol. 23, no. 3, pp. 235–237, 2007. View at Google Scholar · View at Scopus
  6. Y. Tabata, J. Villanueva, S. M. Lee et al., “Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members,” Blood, vol. 105, no. 8, pp. 3066–3071, 2005. View at Publisher · View at Google Scholar
  7. J. Doshi, H. Ochs, and E. W. Gelfand, “X-linked inhibitor of apoptosis (XIAP) deficiency- a novel mutation in XLP patients,” The Journal of Allergy and Clinical Immunology, vol. 121, no. 2, supplement 1, p. 164, 2008. View at Google Scholar
  8. Q. Zhu, T. Torgerson, and H. Ochs, “Rapid flow cytometric screening for SAP and XIAP defects in patients with a phenotype of X-linked lymphoproliferative disease (XLP),” Clinical Immunology, vol. 127, supplement, p. S73, 2008. View at Google Scholar
  9. B. P. Eckelman, G. S. Salvesen, and F. L. Scott, “Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family,” EMBO Reports, vol. 7, no. 10, pp. 988–994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Harlin, S. Birkey Reffey, C. S. Duckett, T. Lindsten, and C. B. Thompson, “Characterization of XIAP-deficient mice,” Molecular and Cellular Biology, vol. 21, no. 10, pp. 3604–3608, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Resch, G. Winsauer, R. Hofer-Warbinek, and R. De Martin, “X-linked inhibitor of apoptosis protein regulates human interleukin-6 in umbilical vein endothelial cells via stimulation of the nuclear factor-κB and MAP kinase signaling pathways,” Pharmacological Reports, vol. 58, supplement, pp. 111–117, 2006. View at Google Scholar · View at Scopus
  12. H. G. Kang, SU. J. Lee, M. H. Chae et al., “Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population,” Cancer Genetics and Cytogenetics, vol. 180, no. 1, pp. 6–13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. U. Salzer, T. Hagena, D. B. Webster, and B. Grimbacher, “Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency,” International Archives of Allergy and Immunology, vol. 147, no. 2, pp. 147–151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Scharenberg, M. C. Hannibal, T. Torgerson et al., “Common editors variable immune deficiency: overview,” in GeneReviews [Internet], R. A. Pagon, T. C. Bird, C. R. Dolan, and K. Stephens, Eds., University of Washington, Seattle, Wash, USA, 2006. View at Google Scholar
  15. A. Aghamohammadi, N. Rezaei, M. Gharagozlou et al., “Hodgkin lymphoma in two siblings with common variable immunodeficiency,” Pediatric Hematology and Oncology, vol. 24, no. 5, pp. 337–342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Aksu, F. Genel, G. Koturoǧlu, Z. Kurugöl, and N. Kütükçüler, “Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique,” Turkish Journal of Pediatrics, vol. 48, no. 1, pp. 19–24, 2006. View at Google Scholar · View at Scopus
  17. R. A. Marsh, J. Villanueva, M. O. Kim et al., “Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations,” Clinical Immunology, vol. 132, no. 1, pp. 116–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. W. M. Comans-Bitter, R. De Groot, R. Van Den Beemd et al., “Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations,” Journal of Pediatrics, vol. 130, no. 3, pp. 388–393, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. R. S. Geha, A. Plebani, and L. D. Notarangelo, “CD40, CD40L, and hyper-igM syndrome,” in Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, H. D. Ochs, E. C. I. Smith, and J. M. Puck, Eds., pp. 251–268, Oxford University Press, New York, NY, USA, 2nd edition, 2007. View at Google Scholar
  20. D. I. Godfrey, K. J. L. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter, “NKT cells: facts, functions and fallacies,” Immunology Today, vol. 21, no. 11, pp. 573–583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ikincioǧullari, T. Kendirli, F. Doǧu, Y. Eǧin, and I. Reisli, “Peripheral blood lymphocyte subsets in healthy Turkish children,” Turkish Journal of Pediatrics, vol. 46, no. 2, pp. 125–130, 2004. View at Google Scholar · View at Scopus
  22. J. P. Schmid, D. Canioni, D. Moshous et al., “Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency),” Blood, vol. 117, no. 5, pp. 1522–1529, 2011. View at Publisher · View at Google Scholar
  23. V. Le Guern, G. Le Roux, A. Martin et al., “Lymphoma complicating common variable immunodeficiency with granulomatous disease: report of two cases,” European Journal of Haematology, vol. 71, no. 6, pp. 459–463, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. N. Polizzotto, J. S. McComish, M. A. Dawson, S. S. Opat, and M. F. Cole-Sinclair, “Burkitt lymphoma in the setting of common variable immunodeficiency,” Annals of Hematology, vol. 88, no. 8, pp. 819–820, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. D. Notarangelo, A. Fischer, R. S. Geha et al., “Primary immunodeficiencies: 2009 update,” Journal of Allergy and Clinical Immunology, vol. 124, no. 6, pp. 1161–1178, 2009. View at Publisher · View at Google Scholar